Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis
Frontiers in Oncology · 04.11.2026 · 16
DOI: 10.3389/fonc.2026.1950349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 04.11.2026. Verfasst von Alexssandra Lima Siqueira dos Santos und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to assess racial disparities in the incidence and mortality of ovarian cancer in Brazil.
Methods
Data were obtained from three national sources: the Population-Based Cancer Registries (2010–2017), the Hospital-Based Cancer Registries, and the Mortality Information System (2000–2023). Crude and age-adjusted rates per 100,000 women were calculated by race (White vs. Black/Brown). Temporal trends were analyzed using Joinpoint regression, estimating the Annual Percent Change (APC).
Results
From 2010–2017, a total of 19,186 incident ovarian cancer cases were recorded, of which 61.9% occurred in White and 30.1% in Black/Brown women. Incidence rates declined among White women (APC –2.36%, p = 0.007) but remained stable among Black/Brown women (APC + 1.77%, p = 0.47). From 2000–2023, mortality increased among Black/Brown women (+1.85%/year, p < 0.001) and remained stable among White women (+0.11%/year, p = 0.39). Hospital-based data (n = 40,762) showed that Black/Brown women were younger (64.4% <60 years), less educated (55.6% <8 years), and more often lived in the Northeast region (53.2%). Compared with White women, they were less frequently staged at diagnosis (49.4% vs. 43.0%, p < 0.001), had longer delays to treatment initiation (≥60 days: 8.3% vs. 6.5%, p < 0.001), and higher early mortality rates (21.4% vs. 19.0%, p < 0.001).
Conclusions
While ovarian cancer incidence is declining among White Brazilian women, Black/Brown women experience stable incidence and rising mortality. Socioeconomic vulnerability, regional disparities, and delays in treatment—rather than biological differences—appear to drive this gap. Implementing targeted policies to ensure equitable access to timely diagnosis and optimal care is essential to reduce these avoidable inequalities.
Zitieren
APA
Santos, A. L. S. D., Mendes, S. V., Junior, J. T. F., Leite, L. F., Thuler, L. C. S., & Melo, A. C. D. (2026). Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1950349
Vancouver
Santos ALSD, Mendes SV, Junior JTF, Leite LF, Thuler LCS, Melo ACD. Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1950349
BibTeX
@article{Santos2026,
author = {Santos, Alexssandra Lima Siqueira dos and Mendes, Sofia Vidaurre and Junior, João Tadeu Fidelis and Leite, Luís Felipe and Thuler, Luiz Claudio Santos and Melo, Andreia Cristina de},
title = {Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1950349}
}
EUVIMED